Gsk (GSK) Inventory Average (2009 - 2026)

Gsk (GSK) has 18 years of Inventory Average data on file, last reported at $8.4 billion in Q2 2026.

• For the quarter ending Q2 2026, Inventory Average rose 6.85% year-over-year to $8.4 billion; the trailing twelve-month figure through Jun 2026 stood at $8.4 billion (up 6.85% YoY), and the FY2025 full-year result was $7.6 billion, up 7.39% from the prior year.
• Inventory Average was $8.4 billion for Q2 2026 at Gsk, up from $8.1 billion in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $8.4 billion in Q2 2026 to a low of $3.6 billion in Q2 2022.
• A 5-year average of $6.9 billion and a median of $7.2 billion in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average tumbled 58.69% in 2022 and surged 86.29% in 2023, its largest moves.
• Gsk's Inventory Average stood at $5.8 billion in 2022, then advanced by 19.42% to $6.9 billion in 2023, then gained by 8.72% to $7.5 billion in 2024, then climbed by 7.82% to $8.1 billion in 2025, then advanced by 3.68% to $8.4 billion in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $8.4 billion in Q2 2026, $8.1 billion in Q1 2026, and $8.1 billion in Q4 2025.